Comparing UroLift Experience Against Rezum
Brief description of study
Prospective, global, multicenter, two-arm, 1:1 randomized study comparing safety and efficacy (through patient reported outcomes) in men with moderate to severe symptomatic Benign Prostatic Hyperplasia (BPH) who are treated with either UroLift® System or Rezum™ System. The primary objective is o determine if Prostatic Urethral Lift (PUL) provides a superior patient experience (i.e., better symptom scores, lower rates of infection and complications associated with surgery, lower catheterization rates and duration, and less interference with daily activities) compared to steam injection.
Clinical Study Identifier: s20-01235
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
